Area of research
Oncology · Cancer Research
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Cancer survivorship and care, and Acute Myeloid Leukemia Research.
Longitudinal response to standard of care in pediatric metabolic dysfunction–associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes
Pancreatic Cancer Surveillance and Survival of High-Risk Individuals
Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias
Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease
The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival
Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis
Cancer spectrum and outcomes in the Mendelian short telomere syndromes
Genome-Wide Gene–Diabetes and Gene–Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia
Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study
Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer
Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy
Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML)
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point<sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced Melanoma
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma
A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts
A two-stage approach to genetic risk assessment in primary care
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
<sup>18</sup>F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience
Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
Feasibility and value of PatientViewpoint: a web system for patient‐reported outcomes assessment in clinical practice
Genetically Defined Subsets of Human Pancreatic Cancer Show Unique <i>In Vitro</i> Chemosensitivity